References
Abay GK, Abraha BH. Trends of Mycobacterium tuberculosis and rifampicin resistance in Adigrat General Hospital, Eastern zone of Tigrai, North Ethiopia. Trop Dis Travel Med Vaccines. 2020;6:14.
Abdella K, Abdissa K, Kebede W, Abebe G. Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia. BMC Public Health. 2015;15:599.
Adane K, Ameni G, Bekele S, Abebe M, Aseffa A. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia. BMC Public Health. 2015;15:572.
Alene KA, Viney K, McBryde ES, Gray DJ, Melku M, Clements ACA. Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study. Transbound Emerg Dis. 2019;66(4):1611-8.
Arega B, Menbere F, Getachew Y. Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia. BMC infectious diseases. 2019;19(1):307.
Assefa D, Seyoum B, Oljira L. Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia. Infect Drug Resist. 2017;10:209-13.
Babure ZK, Bidu KT, Assefa JF, Weldemarium TD, Tufa AF. Risk factors for MDR-TB among Tuberculosis patients of Nekemte Referral Hospital Oromia Regional State, Westernn Ethiopia, 2017. IJBAF. 2019, 7(4): 63-77
Bedewi Z, Mekonnen Y, Worku A, Medhin G, Zewde A, Yimer G, et al. Mycobacterium tuberculosis in central Ethiopia: drug sensitivity patterns and association with genotype. New Microbes New Infect. 2017;17:69-74.
Biru D, Woldesemayat EM. Determinants of Drug-Resistant Tuberculosis in Southern Ethiopia: A Case-Control Study. Infect Drug Resist. 2020;13:1823-9.
Deressa MA, Demissie M. Risk Factors of Multi-Drug Resistant Tuberculosis in Addis Ababa, Ethiopia: A Matched Case-Control Study. OALib. 2014;01(03):1-8.
Desissa F, Workineh T, Beyene T. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. BMC Public Health. 2018;18(1):422.
Dessalegn M, Daniel E, Behailu S, Wagnew M, Nyagero J. Predictors of multidrug resistant tuberculosis among adult patients at Saint Peter Hospital Addis Ababa, Ethiopia. Pan Afr Med J. 2016;25(Suppl 2):5.
Diande´ S, Sangare´ L, Kouanda S, Dingtoumda BI, Mourfou A, et al. Risk Factors for Multidrug-Resistant Tuberculosis in Four Centers in Burkina Faso, West Africa. Microbial Drug Resistance. 2009; 15(3).
Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax. 2006;61(2):158-63.
Fikre A, Tewelde T, Shaweno T. Determinants of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients in Southern Ethiopia: A Case Control Study. J Med Bacteriol. 2019; 8 (1): 1-12.
Flora MS, Amin MN, Karim MR, Afroz S3, Islam S, Alam A, Hossain M. Risk factors of multi-drug-resistant tuberculosis in Bangladeshi population: a case control study. Bangladesh Med Res Counc Bull. 2013; 39: 34-41.
Gobena D, Ameya G, Haile K, Abreha G, Worku Y, Debela T. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study. Ann Clin Microbiol Antimicrob. 2018;17(1):30.
Hamusse SD, Teshome D, Hussen MS, Demissie M, Lindtjorn B. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia. BMC Public Health. 2016;16:593.
Hirpa S, Medhin G, Girma B, Melese M, Mekonen A, et al. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. BMC Public Health. 2013;13:782
Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Annals of internal medicine. 2015;162(11):777-84.
Jaleta KN, Gizachew M, Gelaw B, Tesfa H, Getaneh A, Biadgo B. Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia. Infect Drug Resist. 2017;10:185-92.
Jimma W, Ghazisaeedi M, Shahmoradi L, Abdurahman AA, Kalhori SRN, Nasehi M, et al. Prevalence of and risk factors for multidrug-resistant tuberculosis in Iran and its neighboring countries: systematic review and meta-analysis. Rev Soc Bras Med Trop. 2017;50(3):287-95.
Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg. 2011;39(2):91-2.
Li WB, Zhang YQ, Xing J, Ma ZY, Qu YH, Li XX. Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province, China. Infectious diseases of poverty. 2015;4:14.
Liu Q, Zhu L, Shao Y, Song H, Li G, et al. Rates and risk factors for drug resistance tuberculosis in Northeastern China. BMC Public Health. 2013; 13:1171.
Lomtadze N, Aspindzelashvili R, Janjgava M, Mirtskhulava V, Wright A, et al. . Prevalence and Risk Factors for Multidrug-Resistant Tuberculosis in Republic of Georgia: A Population Based Study. Int J Tuberc Lung Dis. 2009; 13(1): 68–73.
Lukoye D, Ssengooba W, Musisi K, Kasule GW, Cobelens FG, Joloba M, et al. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health. 2015;15:291.
Mehari K, Asmelash T, Hailekiros H, Wubayehu T, Godefay H, Araya T, et al. Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia. Can J Infect Dis Med Microbiol. 2019;2019:2923549.
Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. BMC infectious diseases. 2015;15:461.
Mesfin EA, Beyene D, Tesfaye A, Admasu A, Addise D, Amare M, et al. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PloS one. 2018;13(6):e0197737.
Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K, Mu 370 P-F. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z (Editors). JBI Manual for 371 Evidence Synthesis. JBI, 2020. Available from https://synthesismanual.jbi.global.
Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia. Int J Infect Dis. 2015;39:57-61.
Mulu W, Mekonnen D, Yimer M, Admassu A, Abera B. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. Afr Health Sci. 2015;15(2):368-77.
Munn Z, Aromataris E, Tufanaru C, Stern C, Porritt K, Farrow J, et al. The development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI). Int J Evid Based Healthc. 2019;17(1):36-43.
Pang Y, An J, Shu W, Huo F, Chu N, Gao M, et al. Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008-2017. Emerg Infect Dis. 2019;25(3):457-64.
Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis. 2009;49(9):1350-7.
Petrini B, Hoffner S. Drug-resistant and multidrug-resistant tubercle bacilli. International Journal of Antimicrobial Agents. 1999; 13: 93–97.
Porritt K, Gomersall J, Lockwood C. JBI’s systematic reviews: study selection and critical appraisal. Am J Nurs. 2014;114(6):47–52.
Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar JW. Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis. J Infect. 2018;77(6):469-78.
Przybylski G, Dabrowska A, Pilaczynska-Cemel M, Krawiecka D. Unemployment in TB patients - ten-year observation at regional center of pulmonology in Bydgoszcz, Poland. Med Sci Monit. 2014;20:2125-31.
Raveendran R, Oberoi JK, Wattal C. Multidrug-resistant pulmonary & extrapulmonary tuberculosis: A 13 years retrospective hospital-based analysis. Indian J Med Res. 2015;142(5):575-82.
Riley RD, Higgins JPT, Deek JJ. Interpretation of random effects meta-analyses. BMJ.2011; 342:dS49
Seyoum B, Demissie M, Worku A, Bekele S, Aseffa A. Prevalence and Drug Resistance Patterns of Mycobacterium tuberculosis among New Smear Positive Pulmonary Tuberculosis Patients in Eastern Ethiopia. Tuberc Res Treat. 2014;2014:753492.
Shivekar SS, Kaliaperumal V, Brammacharry U, Sakkaravarthy A, Raj CKV, Alagappan C, et al. Prevalence and factors associated with multidrug-resistant tuberculosis in South India. Sci Rep. 2020;10(1):17552.
Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001; 54(10):1046–55.
Tadesse F. Risk Factors for Multi-drug Resistant Tuberculosis in Addis Ababa, Ethiopia. Universal Journal of Public Health. 2015;3(2):65-70.
Tesfay K, Tesfay S, Nigus E, Gebreyesus A, Gebreegziabiher D, Adane K. More than half of presumptive multidrug-resistant cases referred to a tuberculosis referral laboratory in the Tigray region of Ethiopia are multidrug resistant. Int J Mycobacteriol. 2016;5(3):324-7.
Tsega T, Gedle D, Dilnessa T. Prevalence of Multidrug Resistant Tuberculosis and its Associated Factors among Smear Positive TB Patients at Debre Markos Referral Hospital, Northwest Ethiopia. Global Journal of Medical Research: C Microbiology and Pathology. 2017; 17(2).
Welekidan LN, Skjerve E, Dejene TA, Gebremichael MW, Brynildsrud O, Agdestein A, et al. Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study. PloS one. 2020;15(8):e0236362.
WHO. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. World Health Organization; 2012.
WHO. Global tuberculosis report. Geneva, Switzerland: World Health Organization; 2019.
WHO. Global tuberculosis report. Geneva, Switzerland: World Health Organization; 2020.
Zhao P, Li X, Zhang S, Wang X, Liu C. Social Behaviour Risk Factors for Drug Resistant Tuberculosis in Mainland China: a Meta-analysis. The Journal of International Medical Research 2012; 40: 436 – 445.
Table 1: Characteristics of individual studies on the determinants of drug-resistant tuberculosis in Ethiopia, included in this systematic review and meta-analysis.